EUVIMEDEUVIMED entdecken
Crossref

Multiomics analysis focusing on genome‐wide DNA methylation in paediatric acute promyelocytic leukaemia

Etsuko Murayama iD, Tomoko Kawai iD, Genki Yamato iD, Norio Shiba iD, Kentaro Ohki iD, Yusuke Hara iD, Taeko Kaburagi, Takumi Takizawa iD, Hirohide Kawasaki, Kenichi Yoshida, Yasuhito Nannya iD, Daisuke Tomizawa iD und 6 weitere

British Journal of Haematology · 2026

DOI: 10.1111/bjh.70733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Etsuko Murayama und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan. Hauptthemen laut MEDLINE: DNA Methylation, Leukemia, Promyelocytic, Acute. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Kawano Masanori Memorial Public Interest Incorporated Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We conducted a multiomics analysis of paediatric acute promyelocytic leukaemia (APL) in 36 patients enrolled in the Japanese AML‐P05 study. Targeted deep sequencing identified EP300 mutations ( n = 2) and MYC ‐internal tandem duplication (ITD) ( n = 1), which have not been previously reported in APLs. DNA methylation analysis classified 34 paediatric APLs into two groups: hypermethylation and hypomethylation. Patients in the hypermethylation group had significantly worse outcomes compared to those in the hypomethylation group (3‐year overall survival: 80% vs. 100%, p = 0.043; 3‐year event‐free survival: 73% vs. 95%, p = 0.049). Remarkably, the EBF1‐binding motif was enriched in 82.3% of the CpG sites that were differentially methylated between the hyper‐ and hypomethylation groups, and these sites were predominantly located in enhancer regions. Among the 1427 genes that were significantly differentially expressed between the two groups, EP300 was significantly downregulated in the hypermethylation group. Pathway analyses revealed global transcriptional downregulation in the hypermethylation group; however, MYC , a known EP300 ‐repressed gene, was upregulated within the G2M checkpoint. Our findings suggest a potential link among enhancer‐based epigenetic dysregulation involving DNA methylation at EBF1‐binding sites, EP300 dysfunction and MYC activation. These alterations may contribute to disease heterogeneity and prognosis in paediatric APL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationLeukemia, Promyelocytic, AcuteHumansE1A-Associated p300 ProteinChildFemaleChild, PreschoolMaleMultiomicsAdolescentMutationGene Expression Regulation, LeukemicInfantCpG Islands

Stichwörter der Autor:innen

EBF1EP300MYCAPLmethylationpaediatrics

Substanzen

E1A-Associated p300 ProteinEP300 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan.
  • Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Department of Pediatrics, Yokohama City University, Yokohama, Kanagawa, Japan.
  • Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Department of Hematology/Oncology, Gunma Children's Medical Center, Gunma, Japan.
  • Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan.

ORCID-Profile: Etsuko Murayama, Tomoko Kawai, Genki Yamato, Norio Shiba, Kentaro Ohki, Yusuke Hara, Takumi Takizawa, Yasuhito Nannya, Daisuke Tomizawa

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Kawano Masanori Memorial Public Interest Incorporated Foundation
  • Japanese Society of Hematology
  • Japan Health Research Promotion Bureau
  • National Center for Child Health and Development

Zitieren

APA

Murayama, E., Kawai, T., Yamato, G., Shiba, N., Ohki, K., Hara, Y., Kaburagi, T., Takizawa, T., Kawasaki, H., Yoshida, K., Nannya, Y., Tomizawa, D., Taga, T., Adachi, S., Yuza, Y., Takahashi, H., Ogawa, S., & Hayashi, Y. (2026). Multiomics analysis focusing on genome‐wide DNA methylation in paediatric acute promyelocytic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.70733

Vancouver

Murayama E, Kawai T, Yamato G, Shiba N, Ohki K, Hara Y, et al. Multiomics analysis focusing on genome‐wide DNA methylation in paediatric acute promyelocytic leukaemia. British Journal of Haematology. 2026. doi:10.1111/bjh.70733

BibTeX
@article{Murayama2026,
  author = {Murayama, Etsuko and Kawai, Tomoko and Yamato, Genki and Shiba, Norio and Ohki, Kentaro and Hara, Yusuke and Kaburagi, Taeko and Takizawa, Takumi and Kawasaki, Hirohide and Yoshida, Kenichi and Nannya, Yasuhito and Tomizawa, Daisuke and Taga, Takashi and Adachi, Souichi and Yuza, Yuki and Takahashi, Hiroyuki and Ogawa, Seishi and Hayashi, Yasuhide},
  title = {Multiomics analysis focusing on genome‐wide DNA methylation in paediatric acute promyelocytic leukaemia},
  journal = {British Journal of Haematology},
  year = {2026},
  doi = {10.1111/bjh.70733}
}
Kostenlos starten →